198 related articles for article (PubMed ID: 37056910)
1. Protective Effect of Qingchang Wenzhong Decoction on Colitis and Colitis-Related Carcinogenesis by Regulating Inflammation and Intestinal Fibrosis.
Cheng Y; Li J; Zhang X; Li Y; Shi X; Shi R; Mao T; Kou F; Shi L
J Inflamm Res; 2023; 16():1479-1495. PubMed ID: 37056910
[TBL] [Abstract][Full Text] [Related]
2. Qingchang Wenzhong Decoction ameliorates intestinal inflammation and intestinal barrier dysfunction in ulcerative colitis via the GC-C signaling pathway.
Zhang Y; Li J; Han X; Jiang H; Wang J; Wang M; Zhang X; Zhang L; Hu J; Fu Z; Shi L
J Ethnopharmacol; 2024 Mar; 322():117503. PubMed ID: 38043755
[TBL] [Abstract][Full Text] [Related]
3. Qingchang Wenzhong Decoction reduce ulcerative colitis in mice by inhibiting Th17 lymphocyte differentiation.
Xia S; Chen L; Li Z; Li Y; Zhou Y; Sun S; Su Y; Xu X; Shao J; Zhang Z; Kong D; Zhang F; Zheng S
Phytomedicine; 2022 Dec; 107():154460. PubMed ID: 36182798
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the HIF-dependent intestinal barrier protective mechanism of Qingchang Wenzhong decoction in ulcerative colitis management.
Yang MJ; Zhang YN; Qiao Z; Xu RY; Chen SM; Hu P; Yu HL; Pan Y; Cao J
J Ethnopharmacol; 2024 May; 325():117807. PubMed ID: 38280661
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction.
Sun Z; Pei W; Guo Y; Wang Z; Shi R; Chen X; Zhao X; Chen C; Liu J; Tan X; Yuan W; Mao T
Evid Based Complement Alternat Med; 2019; 2019():9839474. PubMed ID: 31061672
[TBL] [Abstract][Full Text] [Related]
6. Qingchang Wenzhong Decoction Accelerates Intestinal Mucosal Healing Through Modulation of Dysregulated Gut Microbiome, Intestinal Barrier and Immune Responses in Mice.
Sun Z; Li J; Wang W; Liu Y; Liu J; Jiang H; Lu Q; Ding P; Shi R; Zhao X; Yuan W; Tan X; Shi X; Xing Y; Mao T
Front Pharmacol; 2021; 12():738152. PubMed ID: 34557102
[TBL] [Abstract][Full Text] [Related]
7. Qingchang Wenzhong Decoction Attenuates DSS-Induced Colitis in Rats by Reducing Inflammation and Improving Intestinal Barrier Function via Upregulating the MSP/RON Signalling Pathway.
Mao T; Li J; Liu L; Zhao W; Liu Y; Gao K; Guo Y; Xie T; Li N; Shi R
Evid Based Complement Alternat Med; 2017; 2017():4846876. PubMed ID: 29234405
[TBL] [Abstract][Full Text] [Related]
8. Qingchang Wenzhong Decoction Alleviates DSS-Induced Inflammatory Bowel Disease by Inhibiting M1 Macrophage Polarization
Lu Q; Li J; Ding P; Mao T; Shi L; Sun Z; Tan X; Jiang H; Dong J; Li Y; Yang X; Shi R
Biomed Res Int; 2022; 2022():9427076. PubMed ID: 36060126
[TBL] [Abstract][Full Text] [Related]
9. Qingchang Wenzhong Decoction Ameliorates Dextran Sulphate Sodium-Induced Ulcerative Colitis in Rats by Downregulating the IP10/CXCR3 Axis-Mediated Inflammatory Response.
Mao TY; Shi R; Zhao WH; Guo Y; Gao KL; Chen C; Xie TH; Li JX
Evid Based Complement Alternat Med; 2016; 2016():4312538. PubMed ID: 27413386
[TBL] [Abstract][Full Text] [Related]
10. Qingchang Wenzhong Decoction Prevents the Occurrence of Intestinal Tumors by Regulating Intestinal Microbiota and Gasdermin E.
Ren L; Zhang Z; Zhao W; Zhao B; Chen X; Wang Y; Chen Z; Ye J; Yang Y; Cao P
Front Physiol; 2022; 13():917323. PubMed ID: 35910578
[No Abstract] [Full Text] [Related]
11. Yiyi Fuzi Baijiang Powder Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats via Inhibiting the TLR4/NF-
Yang J; Miao L; Xue Y; Wang X
Oxid Med Cell Longev; 2023; 2023():3071610. PubMed ID: 36691639
[TBL] [Abstract][Full Text] [Related]
12. LCN2 as a Potential Diagnostic Biomarker for Ulcerative Colitis-Associated Carcinogenesis Related to Disease Duration.
Kou F; Cheng Y; Shi L; Liu J; Liu Y; Shi R; Peng G; Li J
Front Oncol; 2021; 11():793760. PubMed ID: 35111677
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology based research into the effect and potential mechanism of Portulaca oleracea L. polysaccharide against ulcerative colitis.
Yang Y; Zhou X; Jia G; Li T; Li Y; Zhao R; Wang Y
Comput Biol Med; 2023 Jul; 161():106999. PubMed ID: 37216777
[TBL] [Abstract][Full Text] [Related]
14. In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.
Liu X; Fan Y; Du L; Mei Z; Fu Y
Front Pharmacol; 2021; 12():665102. PubMed ID: 34177580
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Jiawei Zhengqi Powder in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking.
Zhao C; Zhi C; Zhou J
Biomed Res Int; 2023; 2023():8397111. PubMed ID: 36860812
[TBL] [Abstract][Full Text] [Related]
16. Systems pharmacology approach reveals protective mechanisms of Jian-Pi Qing-Chang decoction on ulcerative colitis.
Chen YL; Zheng YY; Dai YC; Zhang YL; Tang ZP
World J Gastroenterol; 2019 Jun; 25(21):2603-2622. PubMed ID: 31210713
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism and experimental verification of Sijunzi Decoction in treatment of ulcerative colitis based on network pharmacology].
Meng-Long Z; Xiao-Yan H; Ya-Lu C; Xin N; Qing-Ting R; Zhen-Yi L; Li-Qun LI
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5362-5372. PubMed ID: 33350195
[TBL] [Abstract][Full Text] [Related]
18. Kuijieyuan Decoction Improved Intestinal Barrier Injury of Ulcerative Colitis by Affecting TLR4-Dependent PI3K/AKT/NF-κB Oxidative and Inflammatory Signaling and Gut Microbiota.
Liu B; Piao X; Niu W; Zhang Q; Ma C; Wu T; Gu Q; Cui T; Li S
Front Pharmacol; 2020; 11():1036. PubMed ID: 32848725
[TBL] [Abstract][Full Text] [Related]
19. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.
Wei M; Li H; Li Q; Qiao Y; Ma Q; Xie R; Wang R; Liu Y; Wei C; Li B; Zheng C; Sun B; Yu B
Biomed Res Int; 2020; 2020():5217405. PubMed ID: 33299870
[TBL] [Abstract][Full Text] [Related]
20. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway.
Xiong T; Zheng X; Zhang K; Wu H; Dong Y; Zhou F; Cheng B; Li L; Xu W; Su J; Huang J; Jiang Z; Li B; Zhang B; Lv G; Chen S
J Ethnopharmacol; 2022 May; 289():115001. PubMed ID: 35085745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
